I agree it's very good news but the stock is locked down for someone's purpose. Complete control.......my 2 cents is someone is accumulating and once they get their fill and we have solid news released then it will be let go.....unfortunately we are left to guess and complain about the lack of movement..... most agonizing stock since being in Ariad.......never again I said
It was a Safety study. The CONCLUSION is as follows:
Preliminary data shows that ADXS11-001 can be safely administered with standard chemoradiation for anal cancer. Further studies of listeria-based immunotherapy with radiation are warranted.